Paper17545527
KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.
Corson TW and 5 others. Clin Cancer Res, 2007. Cited by 86 papers, by iCite.
Cite this record
ConductScience Library. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Papers, record 17545527. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17545527
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Kinesins | Major topic |
| Lung Neoplasms | Major topic |
| Oncogene Proteins | Major topic |
| Cell Line, Tumor | |
| Disease-Free Survival | |
| Female | |
| Gene Expression Profiling | |
| HeLa Cells | |
| Humans | |
| Male | |
| Prognosis | |
| Proportional Hazards Models | |
| RNA, Small Interfering | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA118830 | NCI NIH HHS | United States | R01CA118830 | PubMed and NIH |
Source NIH RePORTER
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42733769 | CXCR4+ circulating tumor cells (CTCs) accumulate in subcutaneous, immune suppressive, CXCL12-loaded-hydrogel. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42733769 | PubMed |
| 42083583 | KIF14-AKT axis regulates ferroptosis sensitivity in triple-negative breast cancer. | Open Life Sci | 2026 | https://conductscience.org/library/papers/42083583 | PubMed |
| 41511650 | KIF14 in cancer biology: implications for diagnosis and therapy. | Clin Exp Metastasis | 2026 | https://conductscience.org/library/papers/41511650 | PubMed |
| 41026307 | Identification of KIF14 as a ferroptosis biomarker for predicting the prognosis and immunotherapy efficacy of bladder cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41026307 | PubMed |
| 40075652 | KIF11 and KIF14 Are a Novel Potential Prognostic Biomarker in Patients with Endometrioid Carcinoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075652 | PubMed |
| 40002279 | Targeting Kinesins for Therapeutic Exploitation of Chromosomal Instability in Lung Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40002279 | PubMed |
| 38033864 | Novel circular RNA circ-0002727 regulates miR-144-3p/KIF14 pathway to promote lung adenocarcinoma progression. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/38033864 | PubMed |
| 36227151 | Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma. | Aging (Albany NY) | 2022 | https://conductscience.org/library/papers/36227151 | PubMed |
| 35836481 | Role of kinesin family member 14 in disease monitoring and prognosis in patients with gastrointestinal cancer. | Oncol Lett | 2022 | https://conductscience.org/library/papers/35836481 | PubMed |
| 35620733 | Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma. | J Oncol | 2022 | https://conductscience.org/library/papers/35620733 | PubMed |
| 35464867 | Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma. | Front Genet | 2022 | https://conductscience.org/library/papers/35464867 | PubMed |
| 35439960 | KIF14 affects cell cycle arrest and cell viability in cervical cancer by regulating the p27Kip1 pathway. | World J Surg Oncol | 2022 | https://conductscience.org/library/papers/35439960 | PubMed |
| 34712733 | Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34712733 | PubMed |
| 34659209 | Microdissection of the Bulk Transcriptome at Single-Cell Resolution Reveals Clinical Significance and Myeloid Cells Heterogeneity in Lung Adenocarcinoma. | Front Immunol | 2021 | https://conductscience.org/library/papers/34659209 | PubMed |
| 34575892 | Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34575892 | PubMed |
| 34495250 | Dysregulation of KIF14 regulates the cell cycle and predicts poor prognosis in cervical cancer: a study based on integrated approaches. | Braz J Med Biol Res | 2021 | https://conductscience.org/library/papers/34495250 | PubMed |
| 34188700 | Gene expression of cytokinesis regulators PRC1, KIF14 and CIT has no prognostic role in colorectal and pancreatic cancer. | Oncol Lett | 2021 | https://conductscience.org/library/papers/34188700 | PubMed |
| 33585227 | KIF21B Expression in Osteosarcoma and Its Regulatory Effect on Osteosarcoma Cell Proliferation and Apoptosis Through the PI3K/AKT Pathway. | Front Oncol | 2020 | https://conductscience.org/library/papers/33585227 | PubMed |
| 33567541 | Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33567541 | PubMed |
| 32509165 | Kinesin family members KIF2C/4A/10/11/14/18B/20A/23 predict poor prognosis and promote cell proliferation in hepatocellular carcinoma. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/32509165 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KIF14 | 9928 | PubTator's text mining | https://conductscience.org/library/genes/9928 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17545527
GET https://conductscience.org/api/papers/v1/17545527/cited_by?page=2